0001104659-24-084362.txt : 20240731 0001104659-24-084362.hdr.sgml : 20240731 20240731162039 ACCESSION NUMBER: 0001104659-24-084362 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240726 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240731 DATE AS OF CHANGE: 20240731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STANDARD BIOTOOLS INC. CENTRAL INDEX KEY: 0001162194 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 770513190 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34180 FILM NUMBER: 241162281 BUSINESS ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502666000 MAIL ADDRESS: STREET 1: 2 TOWER PLACE STREET 2: SUITE 2000 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLUIDIGM CORP DATE OF NAME CHANGE: 20011113 8-K 1 tm2420500d1_8k.htm FORM 8-K
false 0001162194 0001162194 2024-07-26 2024-07-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): July 26, 2024

 

 

Standard BioTools Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

Delaware   001-34180   77-0513190
(State or Other Jurisdiction
of Incorporation) 		  (Commission
File Number)		   (I.R.S. Employer
Identification No.)

 

2 Tower Place, Suite 2000
South San Francisco, California 94080
(Address of Principal Executive Offices) (Zip Code)
 

(650) 266-6000

(Registrant’s Telephone Number, Including Area Code) 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $0.001 per share LAB Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Chief Financial Officer Resignation

 

On July 26, 2024, Jeffrey Black resigned as the Senior Vice President and Chief Financial Officer (serving as the principal financial and accounting officer) of Standard BioTools Inc. (the “Company”), effective as of August 31, 2024. Mr. Black’s resignation was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices, and was driven by his desire to accept an opportunity at another public company. The Company has initiated a search process to identify a permanent successor. Alex Kim, the Company’s Chief Operating Officer, will serve as Standard BioTools’ Interim Chief Financial Officer starting on September 1, 2024.

 

Interim Chief Financial Officer Appointment

 

On July 30, 2024, the Company’s Board of Directors appointed Alex Kim, the Company’s Chief Operating Officer, to serve as Interim Chief Financial Officer of the Company, starting on September 1, 2024, to succeed Mr. Black while the Company searches for a permanent Chief Financial Officer. Mr. Kim currently serves as the Company’s Chief Operating Officer, and biographical information for him can be found under the caption “Management and Corporate Governance – Executive Officers” in the Company’s Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on May 21, 2024, and is incorporated herein by reference. There are no family relationships between Mr. Kim and any director or executive officer of the Company that are required to be disclosed pursuant to Item 401(d) of Regulation S-K, and there are no arrangements or understandings between Mr. Kim and any other persons pursuant to which Mr. Kim was appointed to serve as Interim Chief Financial Officer of the Company. There are no transactions between Mr. Kim and the Company that would be reportable under Item 404(a) of Regulation S-K. Mr. Kim will also continue to serve as the Company’s Chief Operating Officer.

 

A copy of the press release announcing Mr. Black’s resignation as Chief Financial Officer and Mr. Kim’s appointment as Interim Chief Financial Officer is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1 Press release issued by Standard BioTools Inc., dated July 31, 2024.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 31, 2024 STANDARD BIOTOOLS INC.
   
  By: /s/ Michael Egholm, Ph.D.
  Name: Michael Egholm, Ph.D.
  Title: President and Chief Executive Officer

 

 

 

 EX-99.1 2 tm2420500d1_ex99-1.htm EXHIBIT 99.1

 

Exhibit 99.1

 

Standard BioTools Announces Senior Leadership Changes

 

Alex Kim, Chief Operating Officer and Standard BioTools Co-Founder, to Serve as interim Chief Financial Officer Following Departure of Jeffrey Black on August 31, 2024

 

Industry Veteran Sean Mackay Named Chief Business Officer

 

SOUTH SAN FRANCISCO, Calif., July 31, 2024 -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that Jeffrey Black, Chief Financial Officer, will resign from the Company, effective August 31, 2024, to accept an opportunity at another public company. Alex Kim, the Company’s Chief Operating Officer and co-founder of Standard BioTools, will serve as Standard BioTools’ interim Chief Financial Officer starting on September 1, 2024. The Company has initiated a search process to identify a permanent successor.

 

The Company also announced that Sean Mackay, who recently joined as the Company’s Chief Business Officer, will add product management, marketing and investor relations to his responsibilities. Mackay was the founding CEO of IsoPlexis and led the company through several rounds of funding, its IPO and and eventual exit.

 

Michael Egholm, President and Chief Executive Officer of Standard BioTools, said, “Alex has been a core member of our executive team since the formation of Standard BioTools. His leadership in developing our strategic plan makes him the ideal person to assume the interim CFO role. I am also very excited to welcome Sean to SBI – another addition to an incredibly strong team of seasoned operators with deep life science tools experience, all of whom are laser focused on executing our growth strategy.”

 

Egholm concluded, “I want to thank Jeff for his many contributions, including helping us build a strong finance function with key management talent that positions us well for the next phase of our transformation. We wish him all the best.”

 

Black stated, “I am very proud to have been a part of the Standard BioTools team and am confident that the Company is well positioned for continued success. Now is the right time for me personally to start this next chapter in my career. I remain a steadfast believer in Michael, the team, and the SBI vision.”

 

Second Quarter 2024 Financial Results

 

In a separate press release issued today, Standard BioTools issued its second quarter 2024 financial results. The webcast is scheduled to begin at 1:30 p.m. PT, 4:30 p.m. ET. Live audio of the webcast will be available online on the Investor Relations page of the Company’s website at Events & Presentations.

 

About Standard BioTools Inc.

 

Standard BioTools Inc. (Nasdaq:LAB), the parent company of SomaLogic Inc. and previously known as Fluidigm Corporation, has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology and immunotherapy. Learn more at standardbio.com or connect with us on X, Facebook®, LinkedIn, and YouTube™.

 

 

 

For Research Use Only. Not for use in diagnostic procedures.

 

Limited Use Label License and other terms may apply: standardbio.com/legal/salesterms. Patent and License Information: standardbio.com/legal/notices.

 

Trademarks: standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2024 Standard BioTools Inc. (f.k.a. Fluidigm Corporation). All rights reserved.

 

Investor Contact:

 

David Holmes
Gilmartin Group LLC
(332) 330-1031
ir@standardbio.com

 

 

 EX-101.SCH 3 lab-20240726.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 lab-20240726_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 lab-20240726_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Cover
Jul. 26, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jul. 26, 2024
Entity File Number 001-34180
Entity Registrant Name Standard BioTools Inc.
Entity Central Index Key 0001162194
Entity Tax Identification Number 77-0513190
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 2 Tower Place
Entity Address, Address Line Two Suite 2000
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code 650
Local Phone Number 266-6000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.001 per share
Trading Symbol LAB
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://standardbio/role/Cover Cover Cover 1 false false All Reports Book All Reports lab-20240726.xsd lab-20240726_lab.xml lab-20240726_pre.xml tm2420500d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2420500d1_8k.htm": { "nsprefix": "LAB", "nsuri": "http://standardbio/20240726", "dts": { "schema": { "local": [ "lab-20240726.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "lab-20240726_lab.xml" ] }, "presentationLink": { "local": [ "lab-20240726_pre.xml" ] }, "inline": { "local": [ "tm2420500d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://standardbio/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-07-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2420500d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-07-26", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2420500d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://standardbio/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001104659-24-084362-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-084362-xbrl.zip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end XML 16 tm2420500d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001162194 2024-07-26 2024-07-26 iso4217:USD shares iso4217:USD shares false 0001162194 8-K 2024-07-26 Standard BioTools Inc. DE 001-34180 77-0513190 2 Tower Place Suite 2000 South San Francisco CA 94080 650 266-6000 false false false false Common stock, par value $0.001 per share LAB NASDAQ false